EPISODE · Sep 29, 2011 · 9 MIN
Biomarker Selection for Maintenance Therapy in Advanced NSCLC
from Journal of Clinical Oncology (JCO) Podcast
EGFR mutation is a predictive biomarker for maintenance erlotinib but its clinical application is limited. This podcast will explain why.
NOW PLAYING
Biomarker Selection for Maintenance Therapy in Advanced NSCLC
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m